214 related articles for article (PubMed ID: 31310640)
1. Assessment of intratumoral heterogeneity with mutations and gene expression profiles.
Sung JY; Shin HT; Sohn KA; Shin SY; Park WY; Joung JG
PLoS One; 2019; 14(7):e0219682. PubMed ID: 31310640
[TBL] [Abstract][Full Text] [Related]
2. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
3. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
4. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
Song D; Wang X
J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
[TBL] [Abstract][Full Text] [Related]
5. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Li L; Chen C; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
[TBL] [Abstract][Full Text] [Related]
6. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
Kim M; Lee S; Lim S; Kim S
PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
[TBL] [Abstract][Full Text] [Related]
7. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
Liu C; Wang X; Genchev GZ; Lu H
Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
[TBL] [Abstract][Full Text] [Related]
10. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.
Wang R; Dang M; Harada K; Han G; Wang F; Pool Pizzi M; Zhao M; Tatlonghari G; Zhang S; Hao D; Lu Y; Zhao S; Badgwell BD; Blum Murphy M; Shanbhag N; Estrella JS; Roy-Chowdhuri S; Abdelhakeem AAF; Wang Y; Peng G; Hanash S; Calin GA; Song X; Chu Y; Zhang J; Li M; Chen K; Lazar AJ; Futreal A; Song S; Ajani JA; Wang L
Nat Med; 2021 Jan; 27(1):141-151. PubMed ID: 33398161
[TBL] [Abstract][Full Text] [Related]
11. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
Zou M; Liu Z; Zhang XS; Wang Y
Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.
Quek K; Li J; Estecio M; Zhang J; Fujimoto J; Roarty E; Little L; Chow CW; Song X; Behrens C; Chen T; William WN; Swisher S; Heymach J; Wistuba I; Zhang J; Futreal A; Zhang J
Oncotarget; 2017 Mar; 8(13):21994-22002. PubMed ID: 28423542
[TBL] [Abstract][Full Text] [Related]
13. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
Yu J; Hu Y; Xu Y; Wang J; Kuang J; Zhang W; Shao J; Guo D; Wang Y
BMC Cancer; 2019 Mar; 19(1):263. PubMed ID: 30902072
[TBL] [Abstract][Full Text] [Related]
14. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Machine Learning Algorithm Utilization for Lung Cancer Classification Based on Gene Expression Levels.
Podolsky MD; Barchuk AA; Kuznetcov VI; Gusarova NF; Gaidukov VS; Tarakanov SA
Asian Pac J Cancer Prev; 2016; 17(2):835-8. PubMed ID: 26925688
[TBL] [Abstract][Full Text] [Related]
16. Predicting adenocarcinoma recurrence using computational texture models of nodule components in lung CT.
Depeursinge A; Yanagawa M; Leung AN; Rubin DL
Med Phys; 2015 Apr; 42(4):2054-63. PubMed ID: 25832095
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
Jonckheere N; Van Seuningen I
J Transl Med; 2018 Sep; 16(1):259. PubMed ID: 30236127
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal copy number heterogeneity predicts survival rates across cancers.
van Dijk E; van den Bosch T; Lenos KJ; El Makrini K; Nijman LE; van Essen HFB; Lansu N; Boekhout M; Hageman JH; Fitzgerald RC; Punt CJA; Tuynman JB; Snippert HJG; Kops GJPL; Medema JP; Ylstra B; Vermeulen L; Miedema DM
Nat Commun; 2021 May; 12(1):3188. PubMed ID: 34045449
[TBL] [Abstract][Full Text] [Related]
20. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
